Company Insights – Page 4 – media

iBeat’s $5.5M funding paves way for summer launch of cardio wearable

San Francisco-based wearable tech company iBeat announced today that it has closed an additional $5.5 million in seed funding, bringing its total round to $10 million.
- Source: MobiHealthNews
- 687
- May 3, 2018
Company Insights mHealth wearables
Nokia is selling its digital health business back to the co-founder of Withings

Nokia has announced plans to sell its struggling health tech business back to Éric Carreel, co-founder of Withings, the French startup Nokia bought in 2016.
- Source: The Verge
- 596
- May 3, 2018
Company Insights digital health
Aetna rides Medicare Advantage growth, ACA exit to profitable Q1

Aetna has added 250,000 Medicare Advantage members in the first quarter of 2018 on its way to a profitable first quarter as it looks to close a deal with CVS Health.
- Source: FierceHealthcare
- 423
- May 2, 2018
Company Insights
AI-powered doctor assistant Suki lands $20M in funding

Suki, a startup that makes an AI-powered and voice-enabled digital assistant for doctors, has just landed $20 million in a funding round led by Venrock, with participation from First Round, Social Capital, and Marc Benioff.
- Source: MobiHealthNews
- 587
- May 2, 2018
AI Company Insights
Fitbit will use Google Cloud to make its data available to doctors

Fitbit announced yesterday that it plans to utilize Google’s new Cloud Healthcare API, in order to continue its push into the world of serious healthcare devices. It’s a bit of a no-brainer as far as partnerships go.
- Source: Tech Crunch
- 879
- May 2, 2018
Company Insights mHealth wearables
Manufacturing hiccup in China trips up Sanofi’s vaccine sales momentum

After a strong 2017, Sanofi Pasteur got off to a less-than-stellar start this year. In China, inspectors put a temporary kibosh on imports of the pediatric shot Pentaxim, thanks to vaccine batches that failed to pass inspection. That move hobbled the shot's sales—and dragged the rest of the unit down, too.
- Source: fiercepharma
- 635
- May 2, 2018
Company Insights Pentaxim Sanofi
GSK reports Q1 sales decline

GlaxoSmithKline has booked a 2 percent dip in revenues for the first quarter to £7.2 billion, after results were hit by a “significant currency impact” and lower sales of prescription drugs. Profit after tax fell 38 percent to £759 million, while earnings per share dropped to 11.2p from 21.4p a year ago.
- Source: pharmatimes
- 503
- April 28, 2018
Company Insights GSK
Once-daily Trelegy Ellipta gains expanded indication in the US for the treatment of patients with COPD

GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved an expanded indication for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol ‘FF/UMEC/VI’), which means this medicine can now be used by US physicians to treat a broader population of chronic obstructive pulmonary disease (COPD) patients with airflow limitation or who have experienced an acute worsening of respiratory symptoms.
- Source: us.gsk
- 651
- April 27, 2018
Company Insights COPD FDA GSK
Nvidia looks to AI for the future of medical imaging technologies

The name Nvidia usually creates a synapse to the video game industry — or more recently the self-driving car business. But now the computer hardware company is looking to get a foothold in the healthcare industry.
- Source: MobiHealthNews
- 530
- April 27, 2018
AI Company Insights digital health
Lilly and China’s NCCD announce collaboration to advance scientific understanding and care for people living with diabetes and cardiovascular disease

Collaboration between China's National Center for Cardiovascular Diseases and Lilly aims to improve care for people living with Type 2 diabetes in China - The Lilly and NCCD collaboration will address four strategic areas to advance scientific understanding and medical education related to diabetes and cardiovascular disease
- Source: prnewswire
- 535
- April 26, 2018
Company Insights CVD Eli Lilly NCCD

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.